Moss, 29 August 2022

Gentian Diagnostics ASA has today been notified that the following transaction
has been completed by a primary insider in Gentian Diagnostics ASA: Frank Frantzen, board member and primary insider in Gentian Diagnostics ASA, has today
bought 20,000 shares at an average price of NOK 43.50 per share. After the
transaction, Mr. Frantzen holds 20,000 shares in Gentian Diagnostics ASA.

Please refer to the attached notification of trading for further details.

This information is subject to the disclosure requirements in the EU Market
Abuse Regulation and section 5-12 of the Norwegian Securities Trading Act.

For further information, please contact: Njaal Kind, Group CFO,
njaal.kind@gentian.no, +47 91 90 65 25